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Abstract 
 
Introduction:  Cardiovascular disease is the leading cause of death in kidney transplant 
recipients (KTRs).  The prevalence of traditional cardiovascular risk factors is unable to 
justify the increased incidence of cardiovascular events in KTRs.  Inflammation and 
endothelial dysfunction have recently been identified as potential contributors of such 
unconventional cardiovascular phenotypes.  A potential source of inflammation and 
endothelial dysfunction in KTRs, may arise through gut derived endotoxemia.  The objectives 
of this study were therefore to investigate the predictors of inflammation and endothelial 
dysfunction in a prevalent cohort of KTRs.   
Methods:  This single-centre cross-sectional study enrolled 128 clinically stable KTRs.  
Fasting serum samples were collected for measurements of high-sensitivity C-reactive protein 
(hsCRP), soluble E-selectin (sE-selectin), endotoxin, 25-hydroxyvitamin D, adiponectin, uric acid, 
full lipid-profile, and estimated glomerular filtration rate.  Dietary intakes were determined by 3-day 
food diary.  Body composition was measured using bio-impedance based body composition monitor.  
Central obesity was assessed using waist circumference.  Demographic, nutritional and clinical 
predictors of inflammation (hsCRP) and endothelial function (sE-selectin) were assessed. 
Results:  Endotoxemia (R=1.20, p=0.03), reduced vitamin D (R=0.82, p=0.04), high fructose intake 
(R=1.12, p<0.001), decreased dietary fibre intake (R=0.85, p<0.001), and increased waist 
circumference (R=1.05, p=0.002) were associated with elevated hsCRP independently.  Endotoxemia 
was also observed to be associated with raised sE-selectin (R=1.04, p=0.007) independently of 
inflammation (R=1.65, p=0.02).  Other independent predictors of elevated sE-selectin levels include 
low adiponectin levels (R=0.96, p=0.004), increasing waist circumference (R=1.35, p=0.005), male 
(R=1.07, p=0.01), and elevated mean arterial pressure (R=1.35, p=0.006). 
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Conclusion:  Endotoxemia in KTRs contributes to both systemic inflammation and endothelial 
dysfunction.  The independent association between endotoxemia and endothelial dysfunction suggests 
a possible non-inflammatory mechanism of endothelial dysfunction.  Targeting endotoxemia may 
serve as a potent upstream intervention for endothelial dysfunction in KTRs, thereby improving 
cardiovascular outcome in this population.   
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Introduction 
 
Cardiovascular disease (CVD) is the leading cause of mortality and therefore a major driver 
to graft loss in kidney transplant recipients (KTRs)1.  Conventional cardiovascular risk 
factors incompletely explain the increased incidence of cardiovascular events in KTRs2, and 
several studies have highlighted the potential contributions of non-traditional exposures2-4.  
Inflammation and activation of the immune system are believed to provoke atherogenesis in 
the general population5, and inflammation correlates with endothelial dysfunction and 
accelerated atherosclerosis in general6 and chronic kidney disease (CKD)6-9 populations.  
Although less studied in KTRs, recent studies have confirmed inflammation as an important 
and reproducible risk factor for cardiovascular events, all-cause mortality, and graft failure 
among KTRs2,10-15.   
 
Despite its undisputed clinical significance, the factors contributing to inflammation among 
clinically stable KTRs remain under-investigated, and it is unclear whether it is the 
underlying determinants of inflammation or the inflammatory process itself that leads to such 
adverse outcomes.  Thus far, only one study has reported abdominal obesity and smoking as 
important modifiable determinants of inflammation among KTRs12. 
 
Yet recent studies in general and other diseased populations have identified important factors 
contributing to inflammation and endothelial dysfunction.  These include endotoxemia16,17, 
hypovitaminosis D18-21, hyperuricemia22-24,  hypoadiponectinemia25-27, and high dietary intake 
of fructose28-30.  The involvement of such factors in inflammation and endothelial dysfunction 
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among KTRs remain unexplored, and further investigations are warranted due to its 
potentially reversible nature, forming targets for future interventions.  The objectives of this 
study were to specifically examine the contribution of these factors in determining post-
transplantation inflammation among clinically stable KTRs, and to evaluate the independent 
associations of inflammation and its causes on circulating markers of endothelial cell 
damage31.  It is hoped that the findings from this study will help to define the most 
appropriate and plausible targets for intervention in this setting.   
 
Methods 
 
Participants and Study Design 
 
KTRs beyond 1 year post-transplantation, with stable graft function (<10% increase in serum 
creatinine over the preceding 6 months), were recruited to this cross-sectional study between 
April 2010 and April 2013.  Exclusion criteria included episodes of acute rejection within the 
last 6 months, evidence of sepsis in the last 6 weeks, known active malignancy or chronic 
infection, history of thyroid disease or adrenal insufficiency, and contraindications for use of 
bioimpedance-based body composition assessment (implanted or external electronic devices, 
metallic implants, amputations, pregnancy, and lactation).  Of 133 patients approached, 10 
did not participate mainly due to work commitment.  This study was approved by the local 
research ethics committee and was conducted in accordance with the principle of Declaration 
of Helsinki. 
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Data Collection 
 
Demographic and Clinical Parameters 
 
Age, gender, ethnicity, and time post-transplantation were collected from patients’ medical 
records.  Smoking status (never smoked, current, and ex-smoker) and alcohol intake (units 
per week) were collected by questionnaire.  Comorbidity was assessed by Index of Coexistent 
Disease (ICED) using the algorithm described by the Haemodialysis Study32, with the 
required data extracted from patients’ medical records.  In addition, the following clinical 
parameters were retrieved from patients’ medical records:  1) presence of diabetes, either pre-
transplantation (pre-DM), or new onset diabetes after transplantation (NODAT); 2) previous 
acute rejection episodes; 3) dialysis vintage; 4) pre-emptive transplantation; 5) use of statin; 
and 6) immunosuppressive medication usage, either prednisolone, calcineurin inhibitor, or 
adjunctive antiproliferative agent.    
 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured semi-
recumbent with a fully automatic upper-arm digital blood pressure monitor (Spot Vital Signs 
LXi; Welch Allyn).  Six readings over an 8- to 10- minute period were taken, with the first 
reading ignored, and the mean of the remaining five used for subsequent derivation of mean 
arterial pressure (MAP), calculated using the formula (2DBP+SBP)/333.   
 
Laboratory Parameters 
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Blood samples were taken in the morning following an overnight fast for measurements of 
urate, 25-Hydroxyvitamn D, estimated glomerular filtration rate (eGFR) derived using four-
variable modifications of diet in renal disease equation, and full lipid profile including total 
cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides.  
Analyses were undertaken in accredited hospital biochemistry laboratory.   
 
hsCRP was measured using a Tina-quant® cardiac C-reactive protein latex high sensitive 
immunoturbidimetric assay (Roche Diagnostics, Basel, Switzerland).  The intra- and inter- 
assay coefficients of variations were <1.3% and <5.7% respectively. 
 
Adiponectin and sE-selectin were measured using commercially available enzyme-linked 
immunosorbent assay according to manufacturer’s instructions.  The intra- and inter- assay 
coefficients of variation were 3.4% and 5.7% respectively for adiponectin (Linco Ltd, USA) 
34; and <5% and <10% respectively for sE-selectin (R&D Systems, Germany).   
 
Serum endotoxin was analysed using a commercially available QCL-1000 Limulus 
Amebocyte Lysate end point assay (Lonza, USA).  The intra- and inter- assay coefficients of 
variation were 3.9% and 9.6% respectively35. The assay has been previously validated….. 
 
Anthropometric Measurements and Body Composition Parameters 
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Body weight (kg) and height (m) were measured in a standardised procedure with 
participants wearing light clothing without shoes.  Body weight was measured using a digital 
scale to the nearest 0.01kg.  Body height was measured using a stadiometer with the 
participants standing without shoes and feet together, to the nearest 0.01m.  Body mass index 
(BMI, kg/m2) was calculated as weight (Kg) divided by height squared (m2).  Waist 
circumference (WC, cm) was measured with a non-stretchable standard tape measure, to the 
nearest 1cm.  It was positioned over the unclothed abdomen at the midpoint of the lower 
thoracic cage and iliac crest in the midaxillary line, as recommended by the World Health 
Organisation36.   
 
In addition, a well-validated multi-frequency bio-impedance based body composition 
monitor37 (BCM, Fresenius Medical Care, Germany) was used to assess body composition.  
Measurements were carried out in a standard manner while the patient was lying supine in a 
flat and non-conductive bed.  The inbuilt physiological body composition model measures 
whole-body bio-impedance spectroscopy at 50 frequencies (5-1000 kHz) via electrodes 
placed on the wrist (proximal to the transverse) and ankle (arch on the superior side of the 
foot).  Body composition data including lean tissue index (LTI, kg/m2), fat tissue index (FTI, 
kg/m2), and volume expansion (%) were displayed after each measurement.        
 
Dietary Intake Parameters 
 
Fructose, dietary fibre, total fat and saturated fat intakes were estimated by a 3-day food 
dairy.  Participants were given detailed written instructions on completing an accurate dietary 
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record for a 3-day period, which included one weekend day, within 1 week before attending 
the research visit.  These instructions were accompanied by verbal explanation from the 
researcher, which included training in portion size estimation and documentation for both 
dinning in and eating out.  The dietary records were reviewed by the researcher for accuracy 
and completeness at the research visit.  Data was entered into Dietplan 6 P3 (Forestfield 
Software Ltd) nutrition analysis program by the same researcher, avoiding inter-observer 
variation.  Total intakes of all nutrients were calculated by this program. 
 
Statistical Analysis 
 
Statistical analyses were performed using SPSS Statistics 21 (Chicago, IL).  Results were 
presented as mean ± standard deviation (SD) for normally distributed data or median 
(interquartile range, IQR) for non-normally distributed data.   
 
Regression diagnostics were performed.  Linear regression analysis was used to determine 
the associations between predictor variables and the continuously distributed outcome 
variables.  The continuously distributed outcome variables with positively skewed 
distributions underwent logarithmic transformation prior to analysis.    
 
The analyses were performed in two stages.  Initially, the effect of each variable was 
examined in a series of univariate analyses.  Subsequently, the joint effect of variables was 
examined in a multivariate analysis, using a backwards selection procedure to derive the final 
12 
 
model.  A type 1 error rate ≤5% (p≤0.05) was considered significant.  In the multivariate 
regression analyses, only the explanatory variables with univariate p-values of <0.20 were 
included. 
 
Results 
 
Patient Characteristics 
 
The characteristics of the studied population are shown in Table 1.   
 
Determinants of Inflammation (hsCRP) in KTRs 
 
Median serum hsCRP level in this cohort of KTRs was 2.47 (IQR = 1.00-4.89) mg/L.  hsCRP 
levels, (Figure 1a) demonstrated a positively skewed non-gaussian distribution and as such  
logarithmic transformation was performed prior to regression analyses.  A summary of 
univariate and multivariate regression analyses are shown in Table 2.   
 
When examined individually on univariate analysis, higher hsCRP levels were associated 
with increased levels of endotoxin (Ratio, R=1.20; 95% CI=1.07, 1.34; p=0.002), decreased 
levels of vitamin D (R=0.67; 95% CI=0.49, 0.90; p=0.004), increasing urate (R=1.11; 95% 
CI=1.00, 1.22; p=0.007), increased LDL (R=1.13; 95% CI=1.03, 1.23; p=0.01), higher 
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fructose intake (R=1.13; 95% CI=1.12, 1.15; p<0.001), lower dietary fibre intake (R=0.85; 
95% CI=0.70, 0.90; p<0.001), higher saturated fat intake (R=1.14; 95% CI=1.10, 1.18; 
p=0.03), increasing WC (R=1.12; 95% CI=1.06, 1.16; p<0.001), and increased FTI (R=1.39; 
95% CI=1.23, 1.58; p<0.001).   
 
In multivariate analysis, only raised levels of endotoxin (R=1.20; 95% CI=1.08, 1.33; 
p=0.03), decreased levels of vitamin D (R=0.82; 95% CI=0.74, 1.00; p=0.04), increased 
fructose intake (R=1.12; 95% CI=1.09, 1.13; p<0.001), decreased dietary fibre (R=0.85; 95% 
CI=0.79, 1.08; p<0.001), whilst an increasing WC (R=1.05; 95% CI=1.02, 1.08; p=0.002) 
were associated with elevated hsCRP independently. 
 
However in KTRs where endotoxin levels reached 2.50EU/mL there was an 50%? increase in 
HsCRP (Figure 1b) As shown in Figure 1b, when endotoxin level reaches 2.50EU/mL, an 
exponential increase in hsCRP was observed.  Figure 1c presented a negative association 
between vitamin D and hsCRP levels, but the relationship tailed off when vitamin D levels 
rose above 50nmol/L.  In addition, Figure 1d displayed minimal increase in hsCRP with 
increasing intakes of dietary fructose up to 75g per day; for higher intakes of dietary fructose, 
a stronger positive relationship was displayed between the two variables.  Further, Figure 1d 
indicated a negative association between intakes of dietary fibre and hsCRP levels, but this 
relationship is only evident when dietary fibre intakes are below 15g per day.  Moreover, 
Figure 1f revealed a positive association between WC and hsCRP levels, with a more 
pronounced increase when WC is greater than 100cm.  Of note, a substantial proportion of 
the variation in inflammation could be explained by these predictor variables (R2=67%, 
Table 2). 
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Determinants of Endotoxin Levels in KTRs 
 
In light of the observed relationship between endotoxemia and inflammation, and the lack of 
available data on the aetiology of endotoxemia in KTRs, a secondary analysis was performed 
focusing on the factors associated with endotoxemia.  Endotoxin levels, shown in Figure 2a, 
demonstrated positively skewed distribution and underwent logarithmic transformation prior 
to regression analyses.  Median serum endotoxin level in this cohort of KTRs was 1.95 (IQR 
= 1.49-2.38) EU/mL.  A summary of univariate and multivariate regression analyses are 
shown in Table 3. 
 
When examined individually on univariate analysis, higher endotoxin levels were associated 
with lower vitamin D levels (R=0.82; 95% CI=0.74, 0.82; p<0.001), decreased HDL 
(R=0.51; 95% CI=0.32, 1.22; p=0.006), increased LDL (R=1.67; 95% CI=1.27, 2.20; 
p<0.001), raised total cholesterol (R=1.42; 95% CI=1.12, 1.79; p=0.004), higher triglycerides 
(R=1.08; 95% CI=1.06, 1.10; p<0.001), increasing fructose intake (R=1.11; 95% CI=1.11, 
1.22; p<0.001), higher intake of saturated fat (R=1.09; 95% CI=1.06, 1.12; p=0.04), higher 
WC (R=1.22; 95% CI=1.11, 1.49; p=0.004), increased FTI (R=1.65; 95% CI=1.11, 2.46; 
p<0.02), and decreased LTI (R=0.89; 95% CI=0.84, 0.96; p=0.002). 
 
However, in the adjusted model, the only significant independent predictors of endotoxemia 
were decreased vitamin D levels (R=0.90; 95% CI=0.82, 0.90; p<0.001), higher triglycerides 
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(R=1.06; 95% CI=1.04, 1.08; p<0.001), higher fructose intake (R=1.11; 95% CI=1.00, 1.11; 
p=0.01), and increasing WC (R=1.22; 95% CI=1.11, 1.35; p=0.01).   
  
As shown in Figure 2b, a linear negative association between vitamin D and endotoxin levels 
was observed, with 10-unit increase in vitamin D levels associated with 9% increase in 
endotoxin levels.  In contrast, Figure 2c presented a linear positive association between 
triglycerides and endotoxin levels, with 1-unit increase in triglycerides associated with 6% 
increase in endotoxin levels.  In addition, Figure 2d revealed a positive association between 
fructose intake and endotoxin levels, but the association is more evident when intakes of 
fructose are greater than 75g per day.  Similarly, as shown in Figure 2e, the positive 
association between WC and endotoxin levels only becomes apparent when WC is higher 
than 100cm.  A borderline effect of reduced LTI (R=0.95; 95% CI=0.90, 1.00; p=0.07, 
Figure 2f) was found in the final regression model, with a stronger negative association for 
LTI below 15kg/m2.  Finally, the associations between endotoxemia with NODAT (R=1.03; 
95% CI=0.99, 1.06; p=0.08) and pre-existing diabetes (R=1.03; 95% CI=0.99, 1.08; p=0.08) 
emerged in final model of the multivariate analysis, although statistical significance for both 
associations were not reached.  On average, NODAT and pre-existing diabetes were found to 
have higher endotoxin levels by 3% in both cases compared with  patients without diabetes.  
Notably, the variables emerged in the final regression model explained 46% of the variation 
in endotoxin levels (R2=46%, Table 3).   
 
Determinants of Endothelial Function (sE-selectin Levels) in KTRs 
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Median serum sE-selectin level in this cohort of KTRs were 34.2 (IQR = 24.1-44.8) ng/mL.  
sE-selectin levels, (Figure 3a), demonstrated a positively skewed distribution and a  
logarithmic transformation was undertaken prior to parametric analysis.  Table 4 summarised 
the regression analyses pertaining to sE-selectin.   
 
The following predictor variables displayed univariate, unadjusted associations with elevated 
sE-selectin levels:  lower adiponectin levels (R=0.94; 95% CI=0.89, 0.98; p=0.007), higher 
endotoxin levels (R=1.09; 95% CI=1.05, 1.14; p<0.001), increasing hsCRP (R=1.49; 95% 
CI=1.01, 2.22; p=0.04), decreased HDL (R=0.93; 95% CI=0.88, 0.99; p=0.02), increased 
triglycerides (R=1.05; 95% CI=1.02, 1.08; p=0.001), higher fructose intake (R=1.11; 95% 
CI=1.00, 1.22; p=0.04), increasing WC (R=1.35; 95% CI=1.11, 1.64; p=0.003), lower LTI 
(R=0.98; 95% CI=0.97, 0.99; p=0.004), male (R=1.09; 95% CI=1.03, 1.16; p=0.004), 
advancing age (R=1.35; 95% CI=1.11, 1.65; p=0.006), raised MAP (R=1.49; 95% CI=1.11, 
1.82; p=0.006), and use of CNI (R=1.15; 95% CI=1.04, 1.28; p=0.008).   
 
In the adjusted model, the only independent predictors of raised sE-selectin levels were lower 
adiponectin (R=0.96; 95% CI=0.92, 0.99; p=0.004), elevated endotoxin (R=1.04; 95% 
CI=1.03, 1.04; p=0.007), increased hsCRP (R=1.65; 95% CI=1.11, 2.45; p=0.02), higher WC 
(R=1.35; 95% CI=1.11, 1.65; p=0.005), raised MAP (R=1.35; 95% CI=1.11, 1.82; p=0.006), 
and male (R=1.07; 95% CI=1.02, 1.13; p=0.01). 
 
As shown in Figure 3b, there is a negative association between adiponectin and sE-selectin 
levels, but this association is only prominent when adiponectin levels fall below 20µg/mL.  
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Figure 3c demonstrated a positive linear relationship between endotoxin and sE-selectin 
levels, with 1-unit increase in endotoxin level associated with 4% increase in sE-selectin 
levels.  The positive linear relationship between hsCRP and sE-selectin levels is shown in 
Figure 3d, a 10-unit increase in hsCRP level is associated with 6.5% increase in sE-selectin 
level.  In addition, the positive association between WC and sE-selectin is only evident when 
WC is greater than 100cm, shown in Figure 3e.  Likewise, a positive association was 
observed between MAP and sE-selectin (Figure 3f), but this association only holds true with 
MAP higher than 100mmHg.  Moreover, males were found to have 7% higher sE-selectin 
levels compared to female counterpart.  Finally, borderline effects of advancing age (R=1.22; 
95% CI=0.99, 1.49; p=0.07) and use of CNI (R=1.09; 95% CI=0.99, 1.20; p=0.06) were 
observed in the final multivariate regression model.  However, such associations did not 
reach statistical significance.  On average, a 10-year increase in age is associated with 2.2% 
increase in sE-selectin levels; and the use of CNI is associated with 9% higher sE-selectin 
levels compared with non-use of CNI.  A 47% of the variation in sE-selectin was explained 
by the variables in the final multivariate model (R2=46%, Table 4). 
 
Discussion 
 
Although the adverse impact of inflammation on patient and graft outcomes in KTRs is 
uncontested, the drivers of this inflammatory response are incompletely understood, and 
therefore hinders adoption of a rational therapeutic approach.  Similarly, the relationship 
between inflammation and vascular disease is subject to confounders by its underlying 
causes, which are, hitherto unexplored in detail in the field of kidney transplantation.  This 
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study aimed to clarify these relationships, giving rise to plausible underlying mechanisms and 
therapeutic targets.  
This study represents the first evidence in kidney transplantation showing that endotoxemia is 
a significant independent predictor of inflammation in KTRs, and extends the relationship 
seen in non-transplantation CKD16, haemodialysis16, and peritoneal dialysis38 populations.  
Endotoxin, also known as lipopolysaccharide (LPS), is found in the outer cell membrane of 
the cell wall of Gram-negative bacteria that reside in the intestinal lumen as part of gut 
microbiota17.  Upon release into the circulation, LPS stimulates the release of pro-
inflammatory cytokines, resulting in the ‘syndrome’ of systemic inflammation.  Of note, the 
association between endotoxin and hsCRP levels remains minimal up to approximately 2.5 
EU/mL, thereafter an exponential increase in inflammation was seen with increasing 
endotoxemia.  This is in line with the conventional believe that endotoxemia exists with 
endotoxin level rises higher than 2.5 EU/mL39.   
 
Furthermore, it is well recognised that LPS induces endothelial activation and dysfunction17.  
Indeed, endotoxin levels were positively correlated with the levels of circulating sE-selectin, 
the measure of systemic endothelial damage used in the current study.  It is important to note 
that this effect of endotoxemia was independent of inflammation, supporting a direct 
pathogenic role of endotoxin on maladaptation of endothelial cells to fibroblast phenotype 
without invoking an immune response, a relatively novel mechanism of endothelial fibrosis 
in the absence of immune cells40.  Other independent predictors of raised sE-selectin in this 
study included the well-recognised cardiovascular risk factors such as increased waist 
circumference, male gender and raised blood pressure, with some evidence for an effect of 
older age and the use of calcineurin inhibitors.  Of interest, an association between reduced 
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levels of adiponectin and sE-selectin was found, this potentially important relationship has 
previously been recognised in animal model and pre-clinical settings41,42, it is now extended 
to kidney transplantation. 
 
On the basis of the above discussion, it is important to identify modifiable causes of 
endotoxemia.  The current study suggests some potential therapeutic manoeuvres.  It shows 
for the first time in the field of kidney transplantation that endotoxemia is associated with 
increased intakes of dietary fructose and saturated fats, raised serum triglycerides, higher 
waist circumference, and reduced levels of 25-hydroxyvitamin D.  Importantly, these 
represent readily modifiable targets amenable to dietary and lifestyle modification. 
 
The dietary contribution to endotoxemia may be explained by findings extrapolated from pre-
clinical settings and general population, which show that fructose and saturated fat ingestions 
are associated with intestinal bacterial dysbiosis43-45, this in turn modulate intestinal tight 
junction integrity, and subsequently increasing intestinal permeability, bacterial translocation 
and endotoxemia, with the downstream inflammatory consequences described above46.  It 
should be noted that increased endotoxin levels were observed with fructose ingestion greater 
than 75g/day, suggesting that only excessive dietary intake is associated with this effect.  The 
relationship between increased saturated fat intake and endotoxemia was only evident in the 
univariate analysis, although the independent association between higher waist circumference 
and endotoxemia may represent a surrogate for saturated fat intake47.  The independent 
association between lower circulating vitamin D levels and endotoxemia also has an evidence 
base outside transplantation48, and a defined mechanism48. 
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The relationship between waist circumference and endotoxemia is less easily explicable.  On 
one hand, diet-induced obesity and genetic obesity are associated with adverse changes in gut 
microbiota composition, impairing gut barrier function and hence promoting metabolic 
endotoxemia49.  On the other hand, it may even represent a situation of ‘reverse causality’ 
whereby LPS on binding to CD14 on adipocytes serves as a trigger for obesity50.  Further 
interventional studies are required to explore these relationships in detail, but the current 
work serves to generate hypotheses which are amenable to future testing.  In addition, it is 
highly likely that studying the enteric microbiome, which is outside the scope of the current 
study, will provide insight into the basic science of our findings. 
 
In addition to the above-mentioned relationships with endotoxemia, increased fructose intake, 
reduced vitamin D levels, and increased waist circumference displayed associations with 
inflammation which were independent of the relationship between endotoxemia and 
inflammation.  The mechanisms by which excessive fructose intake results in systemic 
inflammation are recognised, but the current study represents the first to describe this 
relationship in kidney transplantation.  Similarly, reduced vitamin D levels as drivers of 
inflammation has been described in varied clinical scenarios51,52, but not detailed in kidney 
transplantation.  In contrast, chronic systemic inflammation in obesity, originating from local 
immune responses in visceral adipose tissue53 is already recognised in kidney 
transplantation12, and further confirmed in the current study.  Of interest, the reciprocal 
relationship between dietary fibre intakes and inflammation is a novel finding of this study, 
particularly when dietary fibre intake falls below 15g/day.  This relationship is consistent 
with findings from previous studies in the general population54-56.  Although the mechanism 
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is incompletely elucidated, it has been suggested that dietary fibre decreases lipid oxidation 
and downstream inflammation55. 
 
This study has limitations that should be acknowledged.  It represents a single-centre 
observational experience, and needs interpretation in this context.  There was little variation 
in the use of immunosuppressive medication, although this homogeneity perhaps helps with 
identification of biologically plausible predictors of endotoxemia, inflammation and 
endothelial dysfunction in this study.  Indeed, the analysis demonstrates that the identified 
predictors are responsible for an impressively large proportion of the variation in outcome.  
Long-term longitudinal follow-up and more detailed understanding of the basic science 
behind these observations will be of benefit.  More importantly, this study sets the scene for 
the implementation of achievable interventions designed to improve cardiovascular outcome 
in kidney transplantation.  
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